Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

The leadership crisis in internal medicine: what can be done?

Reitemeier RJ.

Ann Intern Med. 1991 Jan 1;114(1):69-75.

PMID:
1983937
2.

Teachers as role models.

Reitemeier RJ.

Indiana Med. 1988 Feb;81(2):160-4. No abstract available.

PMID:
3351285
3.

Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.

Moertel CG, Childs DS, O'Fallon JR, Holbrook MA, Schutt AJ, Reitemeier RJ.

J Clin Oncol. 1984 Nov;2(11):1249-54.

PMID:
6491703
4.

The medical-industrial complex: debate.

Relman AS, Bedrosian J, Reitemeier RJ.

Urban Health. 1984 Jul;13(6):30-6, 51. No abstract available.

PMID:
10268161
5.
6.

Cutting costs = using health resources properly.

Reitemeier RJ.

Am Coll Physicians Obs. 1984 Apr;4(4):3. No abstract available.

PMID:
10266331
7.

Medical education in the United States: some current problems and an uncertain future.

Reitemeier RJ.

Henry Ford Hosp Med J. 1984;32(2):123-30. No abstract available.

PMID:
6511449
8.
9.

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group.

Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO Jr, Thomas P, Nave H, Bateman J, Lokich J, Brooks J, Chaffey J, Corson JM, Zamcheck N, Novak JW.

Cancer. 1981 Oct 15;48(8):1705-10.

PMID:
7284971
10.

Classification of patient care.

Reitemeier RJ, Vilter RW, Malach M, Johnson JE 3rd.

Ann Intern Med. 1979 Dec;91(6):924-5. No abstract available.

PMID:
517897
11.
12.

Sounding Boards: Two views of "the doctors' dilemma". As the Board sees it.

Reitemeier RJ, Benson JA Jr.

N Engl J Med. 1978 Dec 7;299(23):1308-9. No abstract available.

PMID:
714100
13.

An unusual extracolonic manifestation of chronic ulcerative colitis.

Symmonds RE Jr, van Heerden JA, Reitemeier RJ.

Dis Colon Rectum. 1978 Oct;21(7):496-500. No abstract available.

PMID:
710242
14.

Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report.

Schein PS, Lavin PT, Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Redlhammer D, Silverman M, Troner M, Douglass HO Jr, Milliron S, Lokich J, Brooks J, Chaffe J, Like A, Zamcheck N, Ramming K, Bateman J, Spiro H, Livstone E, Knowlton A.

Cancer. 1978 Jul;42(1):19-22.

PMID:
352505
15.

Phase II study of cytosine arabinoside in advanced large bowel cancer.

Cullinan SA, O'Connell MJ, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ, Frytak S, Rubin J.

Cancer Treat Rep. 1977 Dec;61(9):1725-6. No abstract available.

PMID:
340037
16.

A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.

McCreary RH, Moertel CG, Schutt AJ, O'Connell MJ, Hahn RG, Reitemeier RJ, Rubin J, Frytak S.

Cancer. 1977 Jul;40(1):9-13.

PMID:
141977
17.

Education to provide primary medical care: panel discussion.

Merrill JA, Reitemeier RJ, Joyce HE, Johnson KG.

Bull N Y Acad Med. 1976 Nov;52(9):1133-9. No abstract available.

18.

Education of the internist: primary care.

Reitemeier RJ.

Bull N Y Acad Med. 1976 Nov;52(9):1126-32. No abstract available.

19.

Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.

Perry MC, Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Treat Rep. 1976 Sep;60(9):1247-50.

PMID:
797447
20.

Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Treat Rep. 1976 Jun;60(6):729-32. No abstract available.

PMID:
954012
21.

Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.

Marciniak TA, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

Cancer Chemother Rep. 1975 Jul-Aug;59(4):761-3. No abstract available.

PMID:
1100228
22.

Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma.

Moertel CG, Schutt AJ, Hahn RG, Marciniak TA, Reitemeier RJ.

Cancer Chemother Rep. 1975 May-Jun;59(3):581-3. No abstract available.

PMID:
1243107
23.

Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.

Moertel CG, Schutt AJ, Hahn RG, Marciniak TA, Reitemeier RJ.

Cancer Chemother Rep. 1975 May-Jun;59(3):577-9. No abstract available.

PMID:
1203884
24.

Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.

Frytak S, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):405-9.

PMID:
1097099
25.

Participation by internists in primary care. Results of a survey of alumni of one large training program.

Reitemeier RJ, Sittell JA Jr, Weeks RE, Daugherty GW, Nobrega FT, Fleming RW.

Trans Am Clin Climatol Assoc. 1975;86:101-11. No abstract available.

26.

Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.

Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

J Natl Cancer Inst. 1975 Jan;54(1):69-71.

PMID:
1117460
27.

100% oxygen inhalation and 5-fluorouracil (NSC-19893) therapy for large bowel carcinoma.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Chemother Rep. 1974 Nov-Dec;58(6):951-2. No abstract available.

PMID:
4614903
28.

Corticosteroid therapy of preterminal gastrointestinal cancer.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer. 1974 Jun;33(6):1607-9. No abstract available.

PMID:
4135151
29.

Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer.

Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

Cancer Chemother Rep. 1974 Mar-Apr;58(2):257-9. No abstract available.

PMID:
4830499
30.

Treatment of advanced gastrointestinal cancer with ememtine (NSC-33669).

Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

Cancer Chemother Rep. 1974 Mar-Apr;58(2):229-32. No abstract available.

PMID:
4598243
31.

Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer.

Kovach JS, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

Cancer. 1974 Feb;33(2):563-7. No abstract available.

PMID:
4812773
32.

A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.

Kovach JS, Schutt AJ, Hahn RG, Reitemeier RJ, Moertel CG.

Oncology. 1974;29(1):34-9. No abstract available.

PMID:
4837137
33.

Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066).

Ravry M, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.

Cancer Chemother Rep. 1973 Nov-Dec;57(4):493-5. No abstract available.

PMID:
4128425
34.

A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.

Schutt AJ, Hahn RG, Reitemeier RJ, Moertel CG.

Cancer Res. 1973 Oct;33(10):2218-20. No abstract available.

35.

Controlled studies of metopimazine for the treatment of nausea and vomiting.

Moertel CG, Reitemeier RJ.

J Clin Pharmacol. 1973 Jul;13(7):283-7. No abstract available.

PMID:
4576417
36.

Treatment of the patient with adenocarcinoma of unknown origin.

Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG.

Cancer. 1972 Dec;30(6):1469-72. No abstract available.

PMID:
4641758
37.

A comparison of 5-fluorouracil administered by slow infusion and rapid injection.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Res. 1972 Dec;32(12):2717-9. No abstract available.

38.

Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Chemother Rep. 1972 Oct;56(5):649-52. No abstract available.

PMID:
4119908
39.

Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer.

Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG.

Cancer Chemother Rep. 1972 Aug;56(4):551-2. No abstract available.

PMID:
4263582
40.

Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Res. 1972 Jun;32(6):1280-2. No abstract available.

41.

A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Res. 1972 Jun;32(6):1278-9. No abstract available.

42.

Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancer.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Chemother Rep. 1972 Apr;56(2):267-9. No abstract available.

PMID:
5043230
43.

Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893).

Moertel CG, Reitemeier RJ, Hahn RG.

Cancer Chemother Rep. 1972 Apr;56(2):245-7. No abstract available.

PMID:
4557738
44.

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.

Cancer Chemother Rep. 1972 Feb;56(1):95-101. No abstract available.

PMID:
5030811
45.

Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.

Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG.

Cancer Chemother Rep. 1971 Jun;55(3):303-7. No abstract available.

PMID:
5115851
46.

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.

Moertel CG, Reitemeier RJ, Hahn RG, Schutt AJ.

Cancer Chemother Rep. 1970 Dec;54(6):471-3. No abstract available.

PMID:
4946016
47.

Combination chemotherapy in gastrointestinal cancer.

Reitemeier RJ, Moertel CG, Hahn RG.

Cancer Res. 1970 May;30(5):1425-8. No abstract available.

48.

Oral methotrexate therapy of gastrointestinal carcinoma.

Moertel CG, Reitemeier RJ, Hahn RG.

Surg Gynecol Obstet. 1970 Feb;130(2):292-4. No abstract available.

PMID:
4189074
49.

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA.

Lancet. 1969 Oct 25;2(7626):865-7. No abstract available.

PMID:
4186452
50.

Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy.

Moertel CG, Reitemeier RJ, Hahn RG.

Cancer Chemother Rep. 1969 Oct;53(5):283-5. No abstract available.

PMID:
4247211

Supplemental Content

Loading ...
Support Center